The global sales of joint replacement are estimated to be worth USD 20.3 billion in 2025 and anticipated to reach a value of USD 32.2 billion by 2035. Sales are projected to rise at a CAGR of 4.7% over the forecast period between 2025 and 2035. The revenue generated by joint replacement in 2024 was USD 19.4 billion.
The increasing osteoarthritis, rheumatoid arthritis, and other degenerative joint disorders incidences are main growth drivers of the joint replacement market. Most prevalent joint disease is osteoarthritis characterized by progressive degradation of cartilage with chronic pain leading to impairment in mobility, further resulting in very low quality-of-life issues.
Many such conditions increasingly manifest due to sedentary lifestyle, ever-growing obesity-related factors, a large aging population, and overall longevity, therefore subjecting individuals' joints for an extended amount of time and leading to considerable damage.
According to facts published by the World Health Organization, in 2019, about 528 million people in the world lived with osteoarthritis; a rise of 113% since 1990. About 73% of those living with osteoarthritis are older than 55 years, and 60% are female.
Global Joint Replacement Industry Analysis
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 19.4 billion |
| Estimated Size, 2025 | USD 20.3 billion |
| Projected Size, 2035 | USD 32.2 billion |
| Value-based CAGR (2025 to 2035) | 4.7% |
These joint disorders affect elderly patients the most as natural aging is characterized by the weakening of the joints and breakdown of cartilage. Therefore, the demand for arthroplasties such as hip, knee, and shoulder arthroplasties, which are well established for the restoration of mobility and pain relief, is increasing.
Advancement of implants, minimal invasive surgery techniques, and effective rehabilitation protocols are improving the outcome and making joint replacement surgeries safer. In addition to these factors, more patients now consider undergoing the procedures due to awareness of their treatment options as well as a good insurance and reimbursement policy, particularly in developed countries.
This trend underscores the rising medical and economic burden of degenerative joint disorders and places the joint replacement market as a critical solution for improving the lives of affected individuals worldwide.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The below table presents the expected CAGR for the global joint replacement market over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2024 to 2035, the business is predicted to surge at a CAGR of 5.9%, followed by a slightly lower growth rate of 5.4% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 5.9% (2024 to 2034) |
| H2 | 5.5% (2024 to 2034) |
| H1 | 4.7% (2025 to 2035) |
| H2 | 4.4% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 4.7% in the first half and decrease moderately at 4.4% in the second half. In the first half (H1) the market witnessed an increase of 120.00 BPS while in the second half (H2), the market witnessed a decrease of 100.00 BPS.
The Increasing Popularity of Cementless Implants Is Increasing Adoption of Joint Replacement.
Cementless implants or press-fit implants are increasingly dominating the joint replacement market because it can integrate biologically with a patient's own bone. Thus, cementless implants do not rely on a cemented construct for stability while cemented ones do. Here, cementless implants are fabricated to stimulate bone into the implant's surface, developing a strong durable bond. This makes them particularly appropriate for younger, more active patients who need implants that could withstand more activity levels for a longer period of time.
The primary advantage of cementless implants is their ability to decrease the risk of long-term complications such as loosening or mechanical failure, which are more prevalent with cemented alternatives. These implants also simplify revision surgeries if needed, because the absence of cement reduces the complexity of procedures. Improvements in implant materials, such as porous titanium coatings and hydroxyapatite layers, enhance osseointegration, further enhancing their clinical success rates.
The most notable would be the cementless femoral stem DePuy Synthes CORAIL Hip System, which is lined with a hydroxyapatite coating to ensure rapid, robust bone ingrowth. There has been mass adoption of these implants because, based on current data, such implants have achieved proven durability without high revision risk. The huge demand for biologically integrated joint replacement solutions presents an opportunity that has been highlighted in the market analysis.
Technological Advancements in Implants is favoring the Growth for Joint Replacement Market
The use of implants has transformed the market for joint replacement, thereby enhancing growth by better surgical outcomes, increased patient satisfaction, and more expansive treatment scopes. The most revolutionary changes, however, come in the form of 3D-printed implants, where a patient-specific solution is provided according to his or her anatomy.
Such implants provide an exact fit and alignment, which means the chances of loosening or malalignment of implants are lower. In addition, 3D printing supports the development of complex porous structures that enhance natural bone integration, thus making implants more stable and durable.
Robotic assistance has also heightened the accuracy in joint replacement. The use of real-time imaging and AI-aided instrumentation by systems like Stryker's MAKO and Zimmer Biomet's ROSA will eliminate errors that were associated with implant placement and orientation. In other words, with robotic assistance, there will be decreased tissue damage and less healing time in addition to less postoperative time at the hospital.
Besides this, the usage of advanced materials such as titanium, ceramic composites, and highly cross-linked polyethylene has further increased implant life and biocompatibility. This material has significantly reduced wear and tear and resulted in a reduced rate of revision surgeries with the quality of life of patients improving.
All of these technological advances are attracting more youthful, active patients while satisfying the increasing demand for durable, customized, and minimally invasive joint replacement solutions.
The Aging Global Population Represents a Substantial Opportunity for The Joint Replacement Market.
Aging in the global population has been a large opportunity for the joint replacement market, as it is more vulnerable to musculoskeletal disorders and degenerative joint conditions. The WHO estimates that by 2050, the world population aged 60 years and above will double and reach 2.1 billion. This demographic shift has significant demand drivers in joint replacement surgeries because factors like osteoarthritis, osteoporosis, and wear out of joints are very prevalent at this age.
Chronic joint pain and impaired mobility afflict elderly patients; the latter does impact the quality of life for many patients. Replacement surgeries involving joints, specifically the knee, hip, and shoulder, aim to improve functional recovery and eliminate discomfort and pain. Technological progress and innovation in the surgical approach as well as the type of implants also increase the chances of successful recovery and improve treatment possibilities for patients who have some kind of background pathology.
The increasing concern for active aging is also the result. Modern seniors are much more active than previous generations, seeking independence and high-performance physical activities. This has increased the demand for high-performance implants that could achieve their style of life performance.
Healthcare infrastructure improvement and government subsidy to aging populations for joint replacement surgeries is further amplifying the market potential in developed and emerging economies.
Complexity of Custom and Patient-Specific Implants Is Emerging as Significant Growth Barrier for Joint Replacement Market.
The adoption of custom and patient-specific implants in the joint replacement market is difficult because of their inherent complexity. These implants are designed to fit individual anatomical variations, and thus, they require advanced imaging technologies such as CT or MRI scans for precise measurements. This initial step is both time-consuming and expensive, adding to the overall cost of the procedure.
After imaging, the design and manufacturing of patient-specific implants involves complex 3D modeling and additive manufacturing techniques. This introduces longer lead times than standard implants, often delaying surgical schedules, which can be a significant drawback in cases where timely intervention is critical, such as trauma or advanced degenerative conditions.
Use of patient-specific implants requires higher preparation levels for surgeons: customized surgical planning and getting used to the special instruments or workflows. In that regard, these implants make surgeries more complicated, which prolongs surgery time and places a higher barrier to the learning curve of the medical teams involved, especially in resource-limited healthcare environments.
Furthermore, due to the associated higher cost, custom implants are not so accessible in cheaper regions or among patients who have insufficient insurance coverage. These factors collectively keep from mass adoption this patient-specific implant despite its perceived clinical benefits and therefore restrains its contribution to overall market growth in joint replacements.
The global joint replacement industry recorded a CAGR of 3.9% during the historical period between 2020 and 2024. The growth of joint replacement industry was positive as it reached a value of USD 19.4 billion in 2024 from USD 16.3 billion in 2020.
The joint replacement market has drastically changed over time due to demographic, technological, and changing patient needs. Traditionally, the main population that entered the market consisted of older patients suffering from osteoarthritis and degenerative joint diseases. The first advancements focused on material science and surgical techniques, as well as switching from metal-on-metal to tougher and more biocompatible materials like titanium, ceramics, and cross-linked polyethylene.
The initial cemented implants were soon taken over by cementless options with their durability and biological fixation properties. Robotic-assisted surgeries, 3D-printed implants, and patient-specific solutions have been added to increase the precision of surgery, shorten recovery times, and improve results.
Recently, the market has expanded to cover the needs of younger, more active patients as the focus of society on quality of life continues to grow.
The trends for the coming time include the smart implants being equipped with sensors to monitor the performance in real-time, growth in the number of out-patient joint replacements, and advancements in minimally invasive techniques. Increased healthcare access in emerging markets and the increased government endeavors to subsidize surgeries further support the market. However, cost and complexity remain restrictions that encourage providing innovation and affordability balance for maximizing market potential. The market is changing towards more personalized, technology-based care solutions.
Tier 1 companies comprise market leaders with a significant market share of 24.1% in global market. These companies engage in strategic partnerships and acquisitions to expand their product portfolios and access cutting-edge technologies. Additionally, they emphasize extensive clinical trials to validate the efficacy and safety of their products. Prominent companies in tier 1 include Johnson & Johnson Services, Inc., Stryker, Zimmer Biomet and Smith+Nephew.
Tier 2 companies include mid-size players having presence in specific regions and highly influencing the local market and holds around 33.5% market share. They typically pursue partnerships with academic institutions and research organizations to leverage emerging technologies and expedite product development.
These companies often emphasize agility and adaptability, allowing them to quickly bring new treatments to market, additionally targeting specific types medical conditions. Additionally, they focus on cost-effective production methods to offer competitive pricing. Prominent companies in tier 2 include DJO, LLC., Arthrex, Inc. and Exactech, Inc
Finally, Tier 3 companies, such as Conformis, MicroPort Orthopedics and Corin Group. They specialize in specific products and cater to niche markets, adding diversity to the industry.
Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the joint replacement sales remains dynamic and competitive.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section below covers the industry analysis for the joint replacement market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle Ease & Africa, is provided. The United States is anticipated to remain at the forefront in North America, with higher market share through 2035. In South Asia & Pacific, India is projected to witness a CAGR of 4.5% by 2035.
| Country | Value CAGR (2025 to 2035) |
|---|---|
| United States. | 2.9% |
| Germany | 3.3% |
| France | 3.5% |
| Spain | 3.6% |
| China | 4.1% |
| India | 4.5% |
| Australia & New Zealand | 3.0% |
| Japan | 3.9% |
United States. joint replacement market is poised to exhibit a CAGR of 2.9% between 2025 and 2035. Currently, it holds the highest share in the North American market.
Comprehensive coverage under insurance as well as favorable and effective reimbursement policy is the drivers of the replacement market in America, which will greatly enhance its accessibility. Public programs like Medicaid and Medicare coupled with private and other insurance players are covering enormous portions of the procedures that are necessary for joint replacement: hospital stay implants, and much more post-operational care services. This does not burden the pocket of the patients and thus results in the consumption of the most necessary procedures timely.
The reimbursement rates in the United States are encouraging health care providers to adopt advanced technologies, such as robotic-assisted surgery and patient-specific implants, thus ensuring the availability of cutting-edge solutions. Further, policies for outpatient surgeries and bundled payment models are fostering cost efficiency while maintaining high procedural volumes.
This favorable financial landscape, combined with the country’s aging population and high prevalence of joint disorders, makes joint replacement surgeries highly accessible, reinforcing the United States dominance in the global market.
Germany joint replacement market is poised to exhibit a CAGR of 3.3% between 2025 and 2035. Currently, it holds the highest share in the Western Europe market, and the trend is expected to continue during the forecast period.
High-volume orthopedic surgery, including joint replacement surgeries, is an important driver for growth in Germany. The population is aging with increasing incidence of degenerative joint diseases such as osteoarthritis, primarily in the hip, knee, and shoulder joints. As such conditions increase in age, there is a subsequent rise in joint replacement surgeries; therefore, Germany represents one of the largest markets in Europe for such procedures.
Another aspect is the progress in surgical technology, including minimal invasive surgery. These have been associated with a higher volume of surgeries because of faster recovery periods and fewer complications. The infrastructure of healthcare and full insurance coverage in the country make these services more accessible to patients, increasing demand. A consistent and rising demand for joint replacement surgeries, especially in the hip and knee, is what has been pushing Germany to become the market leader.
Japan joint replacement market is poised to exhibit a CAGR of 3.9% between 2025 and 2035. Currently, it holds the highest share in the South Asia & Pacific market, and the trend is expected to continue during the forecast period.
Japan has one of the most aging populations worldwide, with an increasingly significant percentage of its citizens above the age of 65 years, age-related degenerative joint diseases like osteoarthritis have risen substantially. Such diseases typically occur in the hip, knee, and shoulder, leading to chronic pain and a lack of mobility. Therefore, it is not surprising that joint replacement surgery is one of the increasingly required operations.
As the elderly population of Japan maintains their mobility and health, demand for joint replacements, such as hip and knee surgical procedures, will increase. However, demand for these procedures is not solely supported by the elders but are also amplified due to Japan's universal healthcare system that permits easy access to treatments.
The ageing population sustains such surgeries, while encouraging developments on the implant technology and minimal invasive procedures, a source of Japan's top position globally in joint replacement.
The section contains information about the leading segments in the industry. By replacement type, the knees segment holds the highest market share of 44.5% in 2025.
| By Replacement Type | Value Share (2025) |
|---|---|
| Knees | 44.5% |
The knee replacement segment is seen to dominate the joint replacement market, thus securing the highest percentage of share as it holds an exceptionally high level of knee-related degenerative conditions like osteoarthritis and rheumatoid arthritis. This segment of joint replacement has great demand due to high cases among aged people since both the mentioned degenerative conditions reduce mobility and worsen quality of life drastically.
Further developments in implantable materials and surgery techniques, for example, the minimally invasive knee replacement as well as robotics-assisted, have improved recovery times and increased patients' outcomes in this regard and thus increased their demand. A significant increase is also seen from the partial knee replacements in younger patients who are much more active compared to the last segment.
Favorable reimbursement policies and high awareness levels regarding knee replacement procedures, mainly in developed regions like the USA, Europe, and Japan, have also driven this growth further. Therefore, it becomes the leading category in the global joint replacement market.
| By End User | Value Share (2025) |
|---|---|
| Hospitals | 34.6% |
By end user, the hospitals segment holds the highest market share of 34.6% in 2025.
The highest market share goes to hospitals, because they are more modem and more skilled medical staff and full post-operative care. Such entities are preferred facilities for joint replacement surgeries because they can handle complex procedures, such as total hip and knee replacements, which require specialized equipment and even just a great deal of expertise.
Hospitals have often been a center of orthopedic care excellence, using the latest technological advancements such as robotic-assisted surgery and 3D-printed implants. They also equip themselves with facilities for preoperative and postoperative care, which is always important in the rehabilitation services, helping patients heal.
Government funding, favorable reimbursement policies, and the high patient influx in hospital settings further strengthen their dominance. In particular, hospitals are preferred in developed regions because of their strict safety standards and multidisciplinary teams, ensuring better patient outcomes in joint replacement procedures.
The market players are using strategies to stay competitive, such as product differentiation through innovative formulations, strategic partnerships with healthcare providers for distribution. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in Joint Replacement Market:
In terms of replacement type, the industry is divided into- extremities, knees and hips.
In terms of fixation type, the industry is segregated into- cemented, cementless, hybrid and reverse hybrid.
In terms of procedure type, the industry is segregated into- total replacement, partial replacement and other procedure types.
In terms of end user, the industry is segregated into- hospitals, orthopedic clinics and other end-uses.
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
The global joint replacement market is projected to witness CAGR of 4.7% between 2025 and 2035.
The global joint replacement industry stood at USD 19.4 billion in 2024.
The global joint replacement market is anticipated to reach USD 32.2 billion by 2035 end.
India is set to record the highest CAGR of 4.5% in the assessment period.
The key players operating in the global joint replacement market include Johnson & Johnson Services, Inc., Stryker, Zimmer Biomet, Smith+Nephew, DJO, LLC., Arthrex, Inc., Exactech, Inc., Conformis, MicroPort Orthopedics and Corin Group.
Explore Therapeutic Device Insights
View Reports
Joint Replacement Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
